Queen's University attracts first Ontario Research Chair

    OTTAWA, April 4 /CNW Telbec/ - Queen's University has appointed the first
of eight new Ontario Research Chairs in Public Policy - part of a $25-million
provincial government initiative to address key policy issues.
    A world leader in the study of health care ethics related to policy, Dr.
Udo Schuklenk will be the Ontario Research Chair in Bioethics. Dr. Schuklenk
was successfully recruited from Glasgow Caledonian University in Scotland,
where he was professor and head of the Centre for Ethics in Public Policy and
Corporate Governance.
    "We are extremely pleased to welcome to Queen's such a highly
accomplished scholar with significant research experience," says Principal
Karen Hitchcock. "His outstanding publication record, international experience
gained at universities in Australia, South Africa, Germany and Britain, and
reputation for public service make Dr. Schuklenk an excellent choice for this
new position. We look forward to his contributions to this important and
highly complex area of public policy."
    "We are delighted to welcome a scholar of Dr. Schuklenk's calibre and
international reputation to Queen's University," said John Gerretsen, MPP
Kingston and the Islands, on behalf of Chris Bentley, Minister of Training,
Colleges and Universities. "Along with the remaining seven Ontario Research
Chairs, we look forward to the benefits of an increased number of leading edge
researchers at our universities who will help ensure that the next generation
of graduate students is prepared to address issues and find novel solutions to
problems of central relevance to all Ontarians."
    Co-editor-in-chief of Bioethics, the official journal of the
International Association of Bioethics, Dr. Schuklenk's publications in this
area have been critically acclaimed. As Chair, he plans to examine the degree
to which market forces should be allowed to dictate the direction of
pharmaceutical research; how communities whose "local knowledge" is
commercially exploited by pharmaceutical companies should be compensated; and
how to define appropriate measures of infectious disease control in conditions
of pandemic.

For further information:

For further information: Nancy Dorrance, Senior Communications Officer,
Communications and Public Affairs, Queen's University, (613) 533-2869

Organization Profile

Queen's University

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890